UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

The Lancet (British edition), 2005-08, Vol.366 (9485), p.579-582

2005

Volltextzugriff (PDF)

Exacerbations of multiple sclerosis in patients treated with gamma interferon

The Lancet (British edition), 1987-04, Vol.1 (8538), p.893-895

1987

Volltextzugriff (PDF)

Pulmonary function in hospitalized infants and toddlers with cystic fibrosis

The Journal of pediatrics, 1998-03, Vol.132 (3), p.405-408

1998

Volltextzugriff (PDF)

The effect of interferon-β on mouse neural progenitor cell survival and differentiation

Biochemical and biophysical research communications, 2009-10, Vol.388 (2), p.181-186

2009

Volltextzugriff (PDF)

Cytokine changes during interferon-beta therapy in multiple sclerosis: Correlations with interferon dose and MRI response

Journal of neuroimmunology, 2007-04, Vol.185 (1), p.168-174

2007

Volltextzugriff (PDF)

Benefits of high-dose, high-frequency interferon beta-1a in relapsing–remitting multiple sclerosis are sustained to 16 months: Final comparative results of the EVIDENCE trial

Journal of the neurological sciences, 2005-12, Vol.239 (1), p.67-74

2005

Volltextzugriff (PDF)

Clinical trials of interferons in multiple sclerosis what have we learned?

Journal of neuroimmunology, 1993-07, Vol.46 (1), p.155-164

1993

Volltextzugriff (PDF)

Selecting relapsing remitting multiple sclerosis patients for treatment: the case for early treatment

Journal of neuroimmunology, 1999-07, Vol.98 (1), p.22-28

1999

Volltextzugriff (PDF)

Interferon-β-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis

Journal of neuroimmunology, 2005, Vol.161 (1), p.169-176

2005

Volltextzugriff (PDF)

Additive effects of copolymer-1 and interferon beta-1b on the immune response to myelin basic protein

Journal of neuroimmunology, 1995-09, Vol.61 (2), p.185-193

1995

Volltextzugriff (PDF)

Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis

Journal of neuroimmunology, 2005-04, Vol.161 (1-2), p.169-176

2005

Volltextzugriff (PDF)

Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells

Journal of neuroimmunology, 1995-08, Vol.61 (1), p.17

1995

Volltextzugriff (PDF)

T8 antigen density on peripheral blood lymphocytes remains unchanged during exacerbations of multiple sclerosis

Journal of neuroimmunology, 1985-01, Vol.9 (6), p.391-398

1985

Volltextzugriff (PDF)

Glatiramer acetate blocks the activation of THP-1 cells by interferon- γ

European journal of pharmacology, 1998-01, Vol.342 (2), p.303-310

1998

Volltextzugriff (PDF)

Interferon β treatment for multiple sclerosis

The Lancet (British edition), 1999-02, Vol.353 (9151), p.494-495

Herndon, Robert M

1999

Volltextzugriff (PDF)

Use of aggregating brain cultures to study the replication of herpes simplex virus types 1 and 2 in central nervous system tissue

Journal of virological methods, 1984-12, Vol.9 (4), p.301-316

1984

Volltextzugriff (PDF)

Leukocytes from multiple sclerosis patients respond to α- and γ-interferons

Journal of neuroimmunology, 1985, Vol.9 (3-4), p.221-227

1985

Volltextzugriff (PDF)

Interferon β treatment for multiple sclerosis

The Lancet (British edition), 1999, Vol.353 (9151), p.494-494

1999

Volltextzugriff (PDF)

The association of cervical spondylosis and multiple sclerosis

Surgical neurology, 1992-10, Vol.38 (4), p.265-270

1992

Volltextzugriff (PDF)

Interferon β-1b reduces antigen presentation to human T-cells

Journal of neuroimmunology, 1995, Vol.56, p.70-70

1995

Volltextzugriff (PDF)

Interferon-β reduces antigen presentation in human cells

Journal of neuroimmunology, 1994-10, Vol.54 (1), p.160-160

1994

Volltextzugriff (PDF)

Adoptive transfer of experimental allergic encephalomyelitis with activated spleen cells: Comparison of in vitro activation by concanavalin A and myelin basic protein

Cellular immunology, 1980-11, Vol.56 (1), p.163-171

Panitch, Hillel S.

1980

Volltextzugriff (PDF)

Adoptive transfer of experimental allergic encephalomyelitis: Requirement for macrophages in activation of spleen cells in vitro by concanavalin A or myelin basic protein

Cellular immunology, 1981-05, Vol.60 (1), p.24-33

1981

Volltextzugriff (PDF)

Trans-blood-brain-barrier albumin leakage and comparisons of intrathecal IgG synthesis calculations in multiple sclerosis patients

Journal of neuroimmunology, 1993-07, Vol.46 (1), p.185-192

1993

Volltextzugriff (PDF)

Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase

Clinica chimica acta, 1986-04, Vol.156 (2), p.179-189

1986

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(33)
Elsevier ScienceDirect Journals Collection
(32)
MEDLINE
(28)
Journals@Ovid Ovid Full Text
(10)
Publisher website
(10)
Business Source Ultimate
(4)
Psychology & Behavioral Sciences Collection (EBSCO)
(4)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

Exacerbations of multiple sclerosis in patients treated with gamma interferon

Pulmonary function in hospitalized infants and toddlers with cystic fibrosis

The effect of interferon-β on mouse neural progenitor cell survival and differentiation

Cytokine changes during interferon-beta therapy in multiple sclerosis: Correlations with interferon dose and MRI response

Benefits of high-dose, high-frequency interferon beta-1a in relapsing–remitting multiple sclerosis are sustained to 16 months: Final comparative results of the EVIDENCE trial

Clinical trials of interferons in multiple sclerosis what have we learned?

Selecting relapsing remitting multiple sclerosis patients for treatment: the case for early treatment

Interferon-β-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis

Additive effects of copolymer-1 and interferon beta-1b on the immune response to myelin basic protein

Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis

Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells

T8 antigen density on peripheral blood lymphocytes remains unchanged during exacerbations of multiple sclerosis

Glatiramer acetate blocks the activation of THP-1 cells by interferon- γ

Interferon β treatment for multiple sclerosis

Use of aggregating brain cultures to study the replication of herpes simplex virus types 1 and 2 in central nervous system tissue

Leukocytes from multiple sclerosis patients respond to α- and γ-interferons

Interferon β treatment for multiple sclerosis

The association of cervical spondylosis and multiple sclerosis

Interferon β-1b reduces antigen presentation to human T-cells

Interferon-β reduces antigen presentation in human cells

Adoptive transfer of experimental allergic encephalomyelitis with activated spleen cells: Comparison of in vitro activation by concanavalin A and myelin basic protein

Adoptive transfer of experimental allergic encephalomyelitis: Requirement for macrophages in activation of spleen cells in vitro by concanavalin A or myelin basic protein

Trans-blood-brain-barrier albumin leakage and comparisons of intrathecal IgG synthesis calculations in multiple sclerosis patients

Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase

Aktive Filter

Suchergebnisse filtern